Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2486 participants.
Also called NCT02089217
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose prevention
- Phase
- Not applicable
- Enrolled
- 2,486 participants
- Registry
-
NCT02089217
-
- Other papers using this trial's data
- Medical Management and Revascularization for Asymptomatic Carotid Stenosis
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States, Australia, Canada, Israel, Spain
- Registry status
- Completed
Technical summary
Registry record NCT02089217. Randomized; single masking; primary purpose prevention. Start 2014-12-09 (actual); primary completion 2025-09-12 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial
- Acronym
- CREST-2
- Condition
- Carotid Stenosis
- Intervention (Procedure)
- Carotid endarterectomy (CEA)
- Intervention (Device)
- Carotid Stenting (CAS)
- Intervention (Other)
- Intensive Medical Management - no CEA
- Intervention (Other)
- Intensive Medical Management - no CAS
- Lead sponsor
- Mayo Clinic
- Collaborator
- National Institute of Neurological Disorders and Stroke (NINDS)
Record details
- Record id
cardio:ct-nct02089217- Content hash
1971e67b6da169cbb02037c158655d9f0af8a4ed669cef4a27e7c6f9662ef7e9